17h
Zacks Investment Research on MSNIs it Apt to Retain HAE Stock in Your Portfolio for Now?Haemonetics Corporation’s HAE impressive Hospital business recovery is poised to drive growth in the upcoming quarters. The robust uptake of the NexSys PCS system bodes well for its long-term growth.
Needham analyst Michael Matson maintained a Buy rating on Haemonetics (HAE – Research Report) today and set a price target of $104.00. The ...
AlphaQuest LLC boosted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 36,520.0% in the fourth quarter, ...
Adnan Syed was formally re-sentenced on Friday, March 14, just over a week after a judge ruled he should not serve any more ...
Needham analyst Mike Matson lowered the firm’s price target on Haemonetics (HAE) to $104 from $108 and keeps a Buy rating on the shares. The ...
Adnan Syed has been resentenced for the 1999 murder of Hae Min Lee, a case that gained national attention after being ...
Research analysts at Zacks Research lowered their FY2025 EPS estimates for shares of Haemonetics in a report released on ...
The original manhwa shows Jinwoo and Cha Hae-In for the last time, and we are here to discuss where Suho's mother is in Solo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results